Approved Formulary
Add Formweb to your mobile device
Approved Formulary
HIGH ALERT: Please read the COMMENTS very carefully.
Do Not Crush Do not crush extended release tablets or capsules. Capsules may be opened and contents taken without crushing or chewing. Liquid dosage forms are available but may differ in dose and frequency of administration from solid dosage
Search results for:
MORPHINE
MORPHINE
- Do Not Crush Do not crush extended release tablets or capsules. Capsules may be opened and contents taken without crushing or chewing. Liquid dosage forms are available but may differ in dose and frequency of administration from solid dosage
- Black Box Warning: Avinza: Alcohol use may result in rapid release of morphine
| Drug Name | Form | Strength | Non-Formulary | Notes |
|---|---|---|---|---|
| MSIR | CAPSULE | 15 MG | ||
| MSIR | CAPSULE | 30 MG | ||
| KADIAN | CAPSULE, EXTENDED RELEASE | 20 mg/12 hrs | ||
| AVINZA | CAPSULE, EXTENDED RELEASE | 30 mg/24 hours | ||
| KADIAN | CAPSULE, EXTENDED RELEASE | 30 mg/12 hrs | ||
| KADIAN | CAPSULE, EXTENDED RELEASE | 50 mg/12 hrs | ||
| AVINZA | CAPSULE, EXTENDED RELEASE | 60 mg/24 hours | ||
| KADIAN | CAPSULE, EXTENDED RELEASE | 60 mg/12 hrs | ||
| KADIAN | CAPSULE, EXTENDED RELEASE | 80 mg/12 hrs | ||
| AVINZA | CAPSULE, EXTENDED RELEASE | 90 mg/24 hours | ||
| KADIAN | CAPSULE, EXTENDED RELEASE | 100 mg/12 hrs | ||
| AVINZA | CAPSULE, EXTENDED RELEASE | 120 mg/24 hours | ||
| KADIAN | CAPSULE, EXTENDED RELEASE | 200 mg/12 hrs | ||
| MORPHINE SULFATE | SOLUTION | 10 mg/5 ml | ||
| MORPHINE SULFATE | SOLUTION | 20 mg/5 ml | ||
| ROXANOL | SOLUTION | 20 mg/ml | ||
| RMS | SUPPOSITORY | 5 mg | ||
| RMS | SUPPOSITORY | 10 mg | ||
| RMS | SUPPOSITORY | 20 mg | ||
| MORPHINE SULFATE | TABLET | 15 mg | ||
| MSIR | TABLET | 30 MG | ||
| MS CONTIN | TABLET, EXTENDED RELEASE | 15 mg | ||
| MS CONTIN | TABLET, EXTENDED RELEASE | 30 mg | ||
| MS CONTIN | TABLET, EXTENDED RELEASE | 60 mg | ||
| MS CONTIN | TABLET, EXTENDED RELEASE | 100 mg | ||
| MS CONTIN | TABLET, EXTENDED RELEASE | 200 MG | ||
| EMBEDA | CAPSULE, EXTENDED RELEASE |
View Other Therapeutic Options: Opioid Agonists:
280808
High Alert Drug
Last updated: Jan. 10, 2017
Class II
ISMP recommended Tall Man Letters MORPHine. Errors have resulted from mix-ups between the abbreviations "MgSO4" for magnesium sulfate and "MS" or "MSO4" for morphine sulfate. Double-checks for appropriateness of drug/dose/pump setting/line placement must be performed during PCA/Epidural use.
The High Risk/High Alert Medication Policy may be found by using the search function in Policies and Procedures.
For oral morphine syringes for the NICU, use the 0.5 mg/1 ml concentration (5 mg/10 ml injection PF)
Capsules may not be opened and given by NG tube.